Government-owned genomics company
Appears in 1 story
Validation partner
Illumina released SpliceAI2 on October 8, a genomic AI model that predicts how DNA variants disrupt RNA splicing. In tests on rare disease data from Genomics England, it found 17% more disease-relevant splice variants than other models.
Updated 2 hours ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
